(015) Sexual Health and Relationship Enhancement (SHARE) for Women with Breast Cancer: Results from a Clinical Trial

Autor: K Carpenter, H Holmes, K Conroy, L Black
Rok vydání: 2023
Předmět:
Zdroj: The Journal of Sexual Medicine. 20
ISSN: 1743-6109
1743-6095
DOI: 10.1093/jsxmed/qdad061.015
Popis: Introduction Sexual difficulties in the context of cancer survivorship remains an important, unsolved problem. Interventions must be efficacious and disseminable. Interventions that can be delivered to heterogeneous survivor groups can maximize impact on patients' quality of life. Objective Test a group psychosexual intervention -- Sexual Health and Relationship Enhancement (SHARE) -- designed for gynecologic cancer survivors in a sample of breast cancer survivors to determine feasibility and efficacy. Methods Participants were breast cancer survivors (N = 28). The majority (53.6%) was diagnosed at stage I (stage II: 35.7%, stage III: 10.7%). The participants were primarily Caucasian (75%) with an average age of 50.6 years (SD = 11.7, range = 29-79) and the majority were partnered (75%). Intent-to-treat (IIT) analyses were conducted for treatment outcomes. Using all available data, mixed effects modeling tested for change in treatment outcomes from the initial assessment to 3-, 6-, and 9-month assessments. Cohen’s d effect sizes were reported at post-treatment (6 months) and follow-up (9 months). The reliable change index was used to determine whether reliable clinical change had been achieved for each patient. Results The 12-session attendance rate was 23%. The mean number of SHARE sessions attended was 9 (SD=3.2). The rate therapy dropout was 10% (n=3). The patients viewed the treatment as helpful; average helpfulness ratings were 2.5 out of 3.0 (SD=0.4) and 84% of ratings fell in the moderately to very helpful range. Using a 0 to 10 point scale for cohesion, the means were 8.0 (SD=1.1) for involvement in the therapy experience and 9.2 (SD=1.1) for felt support. Significant linear effects of time (improvements) were seen for sexual function, satisfaction, and distress (p Conclusions SHARE-B is feasible and efficacious for addressing sexual morbidity following breast cancer, indicating it is likely possible to deliver to women with a variety of disease sites improving scalability of the intervention. Disclosure No
Databáze: OpenAIRE
Externí odkaz: